High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 28 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

CD71 BINDING FIBRONECTIN TYPE III DOMAINS

Application WO-2022221505-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.